Study 200195 App app for iPhone and iPad

4.4 ( 5744 ratings )

Medical
Developer: GlaxoSmithKline PLC

Free

Current version: 1.0, last update: 4 years ago
First release : 25 Apr 2018
App size: 52.28 Mb

Study 200195 App’s purpose is to support GSK Study 200195 (Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Registry for Patients Treated with Strimvelis™ (or GSK269273) Gene Therapy: Long-Term Prospective, Non-Interventional Follow-up of Safety and Effectiveness). Registry participant’s will be able to use the app to enter the required information for the study.